NDC 70518-4532-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4532
- Requested NDC
- 70518-4532-01
- Package NDCs from labels
- 70518-4532-1, 70518-4532-0, 70518-4532-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4532-0 | Gabapentin | 100 in 1 BOX | TABLET, FILM COATED | 100 | 1 | |
| 70518-4532-1 | Gabapentin | 1 in 1 POUCH | TABLET, FILM COATED | 1 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GABAPENTIN | GABAPENTIN | Cipla USA Inc. | 9e4eca9c-6a2c-4ede-a252-1a27094bf594 | 2025-05-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Direct_Rx | 30a2ed14-dcda-f972-e063-6294a90a417c | 2025-04-23 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | McKesson Corporation dba Sky Packaging | 23eb133e-2f74-4219-9892-0a8e770ec032 | 2025-04-17 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Mylan Pharmaceuticals Inc. | cff7de45-148b-4e96-88fd-6052bf75b5f7 | 2025-04-12 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Westminster Pharmaceuticals, LLC | 3ad96553-73a4-4a9b-8a89-10a29b794ed3 | 2025-04-04 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Proficient Rx LP | 7fcce531-bf7c-43b6-bea9-8f0602842c53 | 2025-04-01 | Warnings, Adverse reactions | 310433 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Coupler LLC | 3133c863-d33b-c9d7-e063-6294a90ae898 | 2025-03-25 | Warnings, Adverse reactions | 310433 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Coupler LLC | 3133fc78-dd7a-880c-e063-6394a90a89e1 | 2025-03-25 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Precision Dose, Inc. | 86c93d8b-6286-44e2-93dd-f1b10a5d83da | 2025-03-10 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 87b9171b-7d00-40fa-87ff-a717740efe8a | 2025-03-02 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 64a65366-8577-48f2-9f8e-0332f126d3c1 | 2025-03-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| GABAPENTIN | GABAPENTIN | NuCare Pharmaceuticals, Inc. | 200b61d7-6e4c-923d-e063-6294a90a42cf | 2025-02-21 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 35ac6b11-7b1c-47a0-a4ba-c193a0bb5b01 | 2025-02-20 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | NuCare Pharmaceuticals,Inc. | febf610e-e088-4797-e053-6294a90a3eb5 | 2025-02-04 | Warnings, Adverse reactions | 310433 6CW7F3G59X |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals,Inc. | 07871ab8-254b-e3c2-e063-6294a90a29ab | 2025-02-03 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals,Inc. | 0919fed8-e968-b5ac-e063-6294a90afbff | 2025-02-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | a1ff94a9-69c4-486a-aab2-563c7ed244c8 | 2025-01-30 | Warnings, Adverse reactions | 310433 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Coupler LLC | 2cdbb381-88a2-5c5a-e063-6294a90a3e1e | 2025-01-29 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals, Inc. | 2c65253d-ca49-70eb-e063-6394a90a3cd2 | 2025-01-23 | Warnings, Adverse reactions | 310433 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.